Evoke Pharma, Inc. - Common Shares (EVOK)

CUSIP: 30049G203

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Shares
Shares outstanding
1,582,162
Total 13F shares
59,166
Share change
-9,748
Total reported value
$97,415
Price per share
$1.65
Number of holders
9
Value change
-$18,661
Number of buys
2
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 30049G203?
CUSIP 30049G203 identifies EVOK - Evoke Pharma, Inc. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Evoke Pharma, Inc. - Common Shares (EVOK) as of Q2 2023

As of 30 Jun 2023, Evoke Pharma, Inc. - Common Shares (EVOK) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,166 shares. The largest 9 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Tower Research Capital LLC (TRC), BlackRock Inc., UBS Group AG, NewEdge Advisors, LLC, Concord Wealth Partners, WELLS FARGO & COMPANY/MN, and Federation des caisses Desjardins du Quebec. This page lists 9 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.